Two Sigma Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,877
Closed -$2.02M 1955
2025
Q4
$2.02M Buy
+1,877
New +$1.79M 0.28% 62
2025
Q3
Sell
-352
Closed -$274K 1750
2025
Q2
$274K Sell
352
-648
-65% -$504K 0.03% 714
2025
Q1
$826K Buy
1,000
+649
+185% +$540K 0.13% 201
2024
Q4
$271K Sell
351
-6,276
-95% -$5.2M 0.04% 720
2024
Q3
$5.87M Sell
6,627
-58,718
-90% -$52.8M 0.1% 246
2024
Q2
$59.2M Buy
65,345
+33,023
+102% +$26.4M 0.71% 11
2024
Q1
$25.1M Buy
32,322
+29,503
+1,047% +$21M 0.24% 96
2023
Q4
$1.64M Sell
2,819
-5,748
-67% -$3.36M 0.02% 788
2023
Q3
$4.6M Buy
8,567
+7,623
+808% +$3.93M 0.05% 389
2023
Q2
$443K Sell
944
-189
-17% -$79.3K 0.01% 1523
2023
Q1
$389K Buy
1,133
+355
+46% +$120K 0.01% 1456
2022
Q4
$285K Sell
778
-1,149
-60% -$407K 0.01% 1583
2022
Q3
$623K Sell
1,927
-3,929
-67% -$1.24M 0.02% 922
2022
Q2
$1.9M Sell
5,856
-2,982
-34% -$895K 0.07% 322
2022
Q1
$2.53M Buy
8,838
+7,212
+444% +$1.86M 0.09% 283
2021
Q4
$449K Buy
+1,626
New +$412K 0.02% 590
2021
Q3
Sell
-2,458
Closed -$607K 1767
2021
Q2
$564K Sell
2,458
-144
-6% -$28.9K 0.02% 607
2021
Q1
$486K Buy
2,602
+1,313
+102% +$257K 0.03% 292
2020
Q4
$218K Buy
+1,289
New +$192K 0.01% 1328
2018
Q3
Sell
-26,250
Closed -$2.62M 2829
2018
Q2
$2.24M Buy
+26,250
New +$2.16M 0.01% 852
2017
Q2
Sell
-8,977
Closed -$755K 1036
2017
Q1
$755K Buy
8,977
+3,922
+78% +$314K 0.15% 128
2016
Q4
$372K Buy
5,055
+1,087
+27% +$81K 0.12% 206
2016
Q3
$318K Buy
+3,968
New +$318K 0.11% 275

Other funds holding LLY

Two Sigma Securities's LLY Position: Q1 2026 in Review

Two Sigma Securities sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,877 shares — an estimated $2.02M sold.

Two Sigma Securities first reported a position in LLY in Q3 2016 and held it in 23 quarters. The position peaked at $59.2M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Two Sigma Securities reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 1,877 Eli Lilly shares in Q1 2026, an estimated $2.02M.
  • Two Sigma Securities first reported a position in Eli Lilly in Q3 2016 and held it in 23 quarters.
  • Two Sigma Securities's Eli Lilly position peaked at $59.2M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.